Cabot Co. (NYSE:CBT – Get Free Report) EVP Jeff Ji Zhu sold 14,566 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $113.25, for a total value of $1,649,599.50. Following the transaction, the executive vice president now owns 69,449 shares of the company’s stock, valued at $7,865,099.25. This trade represents a 17.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Jeff Ji Zhu also recently made the following trade(s):
- On Monday, August 26th, Jeff Ji Zhu sold 1,201 shares of Cabot stock. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19.
Cabot Stock Up 0.9 %
CBT stock traded up $1.00 during midday trading on Friday, hitting $110.18. The company’s stock had a trading volume of 20,203 shares, compared to its average volume of 342,983. Cabot Co. has a twelve month low of $70.63 and a twelve month high of $117.46. The stock has a market capitalization of $6.04 billion, a P/E ratio of 16.20, a PEG ratio of 0.94 and a beta of 1.20. The company’s fifty day moving average price is $109.97 and its 200 day moving average price is $102.03. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.08 and a quick ratio of 1.36.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date is Friday, November 29th. Cabot’s dividend payout ratio is currently 25.52%.
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. UBS Group dropped their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. JPMorgan Chase & Co. lowered shares of Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 target price on the stock. in a research report on Monday. Finally, Mizuho raised their price target on shares of Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $105.00.
View Our Latest Research Report on Cabot
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of CBT. Point72 Asia Singapore Pte. Ltd. boosted its position in Cabot by 987.0% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,261 shares of the specialty chemicals company’s stock valued at $476,000 after buying an additional 3,869 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec acquired a new stake in shares of Cabot during the 3rd quarter valued at $226,000. Eventide Asset Management LLC boosted its holdings in Cabot by 19.8% in the third quarter. Eventide Asset Management LLC now owns 122,820 shares of the specialty chemicals company’s stock valued at $13,728,000 after acquiring an additional 20,273 shares during the last quarter. Verition Fund Management LLC increased its position in shares of Cabot by 47.1% during the third quarter. Verition Fund Management LLC now owns 6,911 shares of the specialty chemicals company’s stock worth $772,000 after buying an additional 2,212 shares during the period. Finally, Captrust Financial Advisors raised its position in shares of Cabot by 8.4% in the 3rd quarter. Captrust Financial Advisors now owns 9,090 shares of the specialty chemicals company’s stock worth $1,016,000 after acquiring an additional 704 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles
- Five stocks we like better than Cabot
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top-Performing Non-Leveraged ETFs This Year
- Consumer Staples Stocks, Explained
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- EV Stocks and How to Profit from Them
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.